WWJ -- The Michigan Bureau of Marijuana Regulation and Choice Labs, LLC say five medical marijuana products, including patches, were not properly tested and should be returned to the provisioning centers where they were purchased.
The state's Department of Licensing and Regulatory Affairs announced the recalls on Friday.
The department says, since many medical marijuana patients may be immunocompromised, that Choice Labs and the Bureau of Marijuana Regulation are taking precautionary steps to issue the recall.
Patients or caregivers who have these affected medical marijuana products in their possession should return them to the provisioning center where they were purchased. The department also says provisioning centers have been encouraged to reach out to patients and caregivers that purchased these medical marijuana products from their centers.
This recall affects specific batches and specific products under Processor License PR-000005:• Mary's Transdermal Indica Patches• The Remedy Tincture-Mary's• Mary's Transdermal Patches CBD• The Coltyn 1:1 Tincture• Mary's Transdermal 1:1 Patches
All affected medical marijuana has a label affixed to the container that indicates the license number of the marijuana facility that manufactured the marijuana product, as well as the production batch number assigned to the marijuana product. For the full list of products, batch numbers and provisioning centers affected by the recall, visit the Bureau of Marijuana Regulation's website.
